Clinic and epidemiologic profile of preterm infants with very low birth weight in Rio de Janeiro: 152 patients study;Perfil clínico e epidemiológico de recém-natos prematuros com muito baixo peso no Rio de Janeiro: Estudo de 152 pacientes

Revista Brasileira de Oftalmologia

Volumn 69, Issue 6, 2010, Pages 389-394

  Portes, André Luís Freire ^a,b,c   Baraúna, Helisa ^a   Jeveaux, Giancarlos ^a   Monteiro, Mário Luiz Ribeiro ^c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL GERAL DE BONSUCESSO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blindness prevention; Control; Retinopathy of prematurity; Retinopathy of prematurity epidemiology; Retinopathy of prematurity therapy; Risk factors

Indexed keywords

EID: 79951801292     PISSN: 00347280     EISSN: 19828551     Source Type: Journal    
DOI: 10.1590/S0034-72802010000600008     Document Type: Article

References (13)

1. Fielder AR, Quinn GE. Retinophathy of prematurity. In: Taylor D, Hoyt CS. Pediatric ophthalmology and strabismus. 3rd ed. Philadelphia: W.B. Saunders; 2005. p.506-30.
2. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-25.
3. Gilbert C. Retinopathy of Prematurity: Epidemiology. J Comm Eye Health. 1997;10(21):22-4.
4. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106(4):471-9.
5. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-94.
6. Zin A, Florêncio T, Fortes Filho JB, Nakanami CR, Gianini N, Graziano RM, et al. [Brazilian guidelines proposal for screening and treatment of retinopathy of prematurity (ROP)]. Arq Bras Oftalmol. 2007t;70(5):875-83. Portuguese.
7. Fortes Filho JB, Barros CK, Costa MC, Procianoy RS. Resultados de um programa de prevenção da cegueira pela retinopatia da prematuridade na região sul do Brasil. J Pediatr. (Rio J.) 2007;83(3):209-16.
8. Graziano RM, Leone CR, Cunha SL, Pinheiro AC. Prevalência da retinopatia da prematuridade em recém-nascidos de muito baixo peso. J Pediatr. (Rio J.). 1997;73(6):377-82.
9. Motta MM, Farah ME, Bonomo PP. Retinopatia da prematuridade limiar em crianças submetidas à terapia com surfactante exógeno endotraqueal. Rev Bras Oftalmol. 2008;67(6):292-6.
10. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina. 2008;28(3 Suppl):S19-25.
11. Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ. Absence of histologic retinal toxicity of intravitreal bevacizumabe in a rabbit model. Am J Ophthalmol. 2006;142(1):162-4.
12. Mintz-Hittner HA, Kuffel RR Jr. Intravitreal injection of bevacizumab(Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina. 2008;28(6):831-8.
13. Portes AL, Monteiro ML, Almeida AC, Fusco MA, Miguel NC. Análise clínica e morfológica do bevacizumabe intra-vítreo na retina de coelhos recém-natos a termo [resumo]. In: 35° Congresso Brasileiro de Oftalmologia; 2009 Ago 24-27; Belo Horizonte, Minas Gerais.